Inclusion Criteria:  Patients will be recruited if they have significant/advanced fibrosis or cirrhosis confirmed by MRE  Exclusion Criteria:  decompensated cirrhosis (variceal bleeding, ascites, hepatic hydrothorax, hepatic encephalopathy), portal vein thrombosis, alcohol intake >20g within last 2 years, concurrent chronic liver disease (chronic hepatitis C infection, autoimmune hepatitis, Wilson's disease, hemochromatosis, primary biliary cholangitis, drug-induced), history of malignancy including hepatocellular carcinoma (HCC), pregnancy, contraindications to empagliflozin (estimated glomerular filtration rate (eGFR) <45mL/min/1.73m2, recurrent genitourinary tract infections, gangrene, allergy), contraindications to MRI (e.g., claustrophobia, implanted devices with ferromagnetic properties).